− Takeda continues to execute on global strategy focused on life-transforming treatments for patients living with complex and rare diseases − Fast tracks innovative medicines to patients in China in key business areas Takeda Pharmaceutical Company Limited (TAK) today announced that it has entered into an agreement to divest a portfolio of non-core prescription pharmaceutical products sold in Chin...
The vitamin c supplements market is poised to decline by USD 2.52 bn during 2020-2024, decelerating at a CAGR of over 7% during the forecast period. This press release features multimedia. Worried about the impact of COVID-19 on your Business? Get FREE Sample Report in Minutes!
Amring Pharmaceuticals Inc., a generic pharmaceutical company, announced entering into an agreement with Ferring International Center S.A. on December 1, 2020 that will further strengthen its position in the marketplace with the acquisition of the global rights to LYSTEDA®, a first-in-class, non-hormonal therapy indicated specifically for treatment of women with cyclic heavy menstrual bleeding.
The weight loss supplement market is expected to grow by $ 1.33 bn, progressing at a CAGR of over 5% during the forecast period. This press release features multimedia. The growing obese population is one of the major factors propelling market growth.
The pet dietary supplements market is poised to grow by USD 666.55 mn during 2020-2024, progressing at a CAGR of about 5% during the forecast period. This press release features multimedia. Worried about the impact of COVID-19 on your Business? Get FREE Sample Report in Minutes!
The heparin market is poised to grow by USD 941.2 mn during 2020-2024, progressing at a CAGR of almost 3% during the forecast period. This press release features multimedia. Worried about the impact of COVID-19 on your Business? Get FREE Sample Report in Minutes!
. This announcement is for our U.S.$5,000,000,000 Euro Medium Term Note Programme. November 11, 2020. To whom it may concern: Company Name: Mitsui Chemicals, Inc. Name of Representative: Osamu Hashimoto President & CEO Contact: Junichi Inoue General Manager of Corporate Communications Division Phone: +81-3-6253-2100.
The analytical instrument market research report from Technavio indicates neutral growth in the short term as the business impact of COVID-19 spreads. This press release features multimedia. Get detailed insights on the COVID-19 pandemic Crisis and Recovery analysis of the analytical instrument market.
DoseID, the first of its kind industry consortium for best practices in RFID use in healthcare, announced its founding board of directors. The DoseID Board of Directors is made up of representatives from five founding DoseID member companies; Sandoz, Omnicell, Kit Check, CCL, and Hikma.
News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
PDF’s require Adobe® Reader® and will open in a new window.
